Cost Effectiveness of Imatinib, Dasatinib, and Nilotinib as First-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia in China
Li, Na, Zheng, Bin, Cai, Hong-Fu, Yang, Jing, Luo, Xiao-Feng, Weng, Li-Zhu, Zhan, Feng-Mei, Liu, Mao-BaiLanguage:
english
Journal:
Clinical Drug Investigation
DOI:
10.1007/s40261-017-0587-z
Date:
October, 2017
File:
PDF, 1.10 MB
english, 2017